Live from the NIH registry
Studies recruiting near Des Moines right now
Top 25 of 229 recruiting studies, sorted by proximity — each links to its official registry page
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Blank Children's Hospital — Des Moines, Iowa (1.9 mi)
· Sponsor: Children's Oncology Group
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia (CLL)
Phase 2
Interventional 75 participants sought
Des Moines Oncology Research Association /ID# 232606 — Des Moines, Iowa (1.9 mi)
· Sponsor: AbbVie
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Iowa Methodist Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Iowa Methodist Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Blank Children's Hospital — Des Moines, Iowa (1.9 mi)
· Sponsor: Children's Oncology Group
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Iowa Diabetes and Endocrinology Research Center /ID# 256750 — West Des Moines, Iowa (5.2 mi)
· Sponsor: AbbVie
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Mission Blood & Cancer Care ( Site 0114) — Waukee, Iowa (14.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
University of Iowa Health Care. ( Site 0057) — Waukee, Iowa (14.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
Arterial Disease of Legs, Below-the-knee Obstruction
N/A
Interventional 368 participants sought
Unity Point Health Des Moines — Des Moines, Iowa (1.9 mi)
· Sponsor: Concept Medical Inc.
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Phase 3
Interventional 700 participants sought
Mission Cancer Blood University of Iowa Health Care — Waukee, Iowa (14.5 mi)
· Sponsor: Janssen Research & Development, LLC
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Mitral Valve Regurgitation
N/A
Interventional 1,056 participants sought
MercyOne Des Moines Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: Medtronic Cardiovascular
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Mercy Medical Center - Des Moines — Des Moines, Iowa (1.9 mi)
· Sponsor: NRG Oncology
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — West Des Moines, Iowa (5.2 mi)
· Sponsor: Akero Therapeutics, Inc
Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
Healthy Adult Participants
N/A
Observational 15 participants sought
Decentralized / At-Home Participation (U.S.) — Des Moines, Iowa (1.9 mi)
· Sponsor: Ecotera Health LLC
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Iowa Methodist Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: SWOG Cancer Research Network
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Oligometastatic Prostate Cancer (OMPC)
Phase 3
Interventional 450 participants sought
Unity Point Clinic — Des Moines, Iowa (1.9 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
The Iowa Clinic, PC — West Des Moines, Iowa (5.2 mi)
· Sponsor: Boehringer Ingelheim
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Iowa Methodist Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Iowa Methodist Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: NRG Oncology
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 1,000 participants sought
Mission Cancer Blood — Waukee, Iowa (14.5 mi)
· Sponsor: Janssen Research & Development, LLC
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Phase 2
Interventional 130 participants sought
Mission Blood and Cancer - MercyOne Cancer Center — Waukee, Iowa (14.5 mi)
· Sponsor: Hoffmann-La Roche
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma
Phase 3
Interventional 62 participants sought
Blank Children's Hospital — Des Moines, Iowa (1.9 mi)
· Sponsor: Children's Oncology Group
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Non-small Cell Lung Cancer
Phase 3
Interventional 320 participants sought
Iowa Methodist Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: Canadian Cancer Trials Group
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Mantle Cell Lymphoma, B Cell Lymphoma
Phase 3
Interventional 300 participants sought
Mission Cancer and Blood — Waukee, Iowa (14.5 mi)
· Sponsor: BeOne Medicines
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Metastatic Castration-resistant Prostatic Neoplasms
Phase 3
Interventional 1,203 participants sought
Mission Cancer Blood — Waukee, Iowa (14.5 mi)
· Sponsor: Janssen Research & Development, LLC